Literature DB >> 12577118

Visual loss with papilledema in Guillain-Barre syndrome.

P S Kharbanda1, S Prabhakar, V Lal, C P Das.   

Abstract

Papilledema and raised intracranial pressure have been reported in association with Guillain-Barre syndrome. Papilledema is usually asympotomatic or associated with mild visual field defects, without any visual loss. The cerebrospinal fluid protein is usually reported to be high. A case of a 35 year old lady is reported, who presented with headache, diplopia and progressive visual loss in both eyes and limb weakness with hyporeflexia. Optic fundus examination showed bilateral papilledema. She had features of pseudotumor cerebri. Nerve conduction studies were suggestive of polyradiculopathy. The unusual things in this case, were the profound visual loss normal cerebrospinal fluid profiles and the presentation of papilledema before the limb weakness.

Entities:  

Mesh:

Year:  2002        PMID: 12577118

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  4 in total

1.  Intracranial hypertension causing polyradiculopathy and late or absent F-waves.

Authors:  O Kincaid; J Rowin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

2.  An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.

Authors:  Sonali Sihindi Chapa Gunatilake; Rohitha Gamlath; Harith Wimalaratna
Journal:  BMC Neurol       Date:  2016-09-05       Impact factor: 2.474

3.  Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome.

Authors:  Christina Doxaki; Eleftheria Papadopoulou; Iliana Maniadaki; Nikolaos G Tsakalis; Konstantinos Palikaras; Pelagia Vorgia
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

4.  Increased intracranial pressure in Guillain-Barré syndrome: A case report.

Authors:  Pan-Pan Zhao; Qian-Kun Ji; Rui-Bin Sui; Rong Zhang; Li-Jun Zhang; Zhi-Xiu Xu; Qing Li; Si-Bei Ji; Jian-Hua Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.